IP Library Granted Patent US 7,939,089
Granted Patent B2
US 7,939,089 · App. 11/794,372 · Granted May 10, 2011

Attenuated mycobacteria as vectors for gene delivery to mammalian cells

Assignee: Albert Einstein College of Medicine of Yeshiva University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,939,089
App. No.
11/794,372
Granted
May 10, 2011
Kind
B2
Abstract

Provided are mycobacteria comprising a recombinant gene operably liked to a mammalian promoter that directs expression of the recombinant gene from a mammalian cell. Also provided are mammalian cells comprising the above mycobacteria. Additionally provided are mycobacterial plasmids capable of replication in a mycobacterium. Further provided are methods of expressing a recombinant gene in a mammalian cell.

Claims (31)

1. A mycobacterium comprising a recombinant gene operably linked to a mammalian promoter that directs expression of the recombinant gene from a mammalian cell, wherein the mycobacterium is M. smegmatis or M. bovis BCG, and wherein the mycobacterium overexpresses (i) RepA, (ii) RepB or (iii) RepA and RepB.

2. The mycobacterium of claim 1 , wherein the mycobacterium is M. bovis BCG.

3. The mycobacterium of claim 1 , wherein the mycobacterium is M. smegmatis.

4. The mycobacterium of claim 1 , wherein the mycobacterium overexpresses RepA.

5. The mycobacterium of claim 1 , wherein the mycobacterium overexpresses RepB.

6. The mycobacterium of claim 1 , wherein the mycobacterium overexpresses RepA and RepB.

7. The mycobacterium of claim 1 , wherein the mycobacterium is capable of hyperconjugation.

8. The mycobacterium of claim 1 , wherein the promoter is a human cytomegalovirus immediate-early promoter.

9. The mycobacterium of claim 1 , wherein the gene encodes a protein.

10. The mycobacterium of claim 9 , wherein the protein is an antigen of a human pathogen.

11. The mycobacterium of claim 10 , wherein the human pathogen is influenza.

12. The mycobacterium of claim 1 , wherein the gene is on a mycobacterial plasmid.

13. A mammalian cell comprising the recombinant mycobacterium of claim 1 .

14. The cell of claim 13 , wherein the mycobacterium is M. bovis BCG.

15. The cell of claim 13 , wherein the mycobacterium is M. smegmatis.

16. The cell of claim 13 , wherein the mycobacterium overexpresses RepA.

17. The cell of claim 13 , wherein the mycobacterium overexpresses RepB.

18. The cell of claim 13 , wherein the mycobacterium overexpresses RepA and RepB.

19. A mycobacterial plasmid capable of replication in a mycobacterium, wherein the plasmid comprises a recombinant gene operably liked to a mammalian promoter that directs expression of the recombinant gene from a mammalian cell, wherein the mycobacterium is M. smegmatis or M. bovis BCG, and wherein the mycobacterial plasmid directs overexpression of (i) RepA, (ii) RepB or (iii) RepA and RepB.

20. The plasmid of claim 19 , wherein the mycobacterium is M. bovis BCG.

21. The plasmid of claim 19 , wherein the mycobacterium is M. smegmatis.

22. The plasmid of claim 19 , which directs overexpression of RepA.

23. The plasmid of claim 19 , which directs overexpression of RepB.

24. The plasmid of claim 19 , which directs overexpression of RepA and RepB.

25. A method of expressing a recombinant gene in a mammalian cell, the method comprising infecting the cell with the mycobacterium of claim 1 .

26. The method of claim 25 , wherein the mycobacterium is M. bovis BCG.

27. The method of claim 25 , wherein the mycobacterium is M. smegmatis.

28. The method of claim 25 , wherein the mycobacterium overexpresses RepA.

29. The method of claim 25 , wherein the mycobacterium overexpresses RepB.

30. The method of claim 25 , wherein the mycobacterium overexpresses RepA and RepB.

31. The method of claim 25 , wherein the gene encodes an antigen of a human pathogen.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 5, 2013
From: YESHIVA UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031579/0849 →
Continuity (2)
Provisional Application 60643535 · Jan 12, 2005
Related Publication 20080268541A1 · Oct 30, 2008